HCOs & Patients

This section is for Health Consumer Organisations and patients, and provides relevant and useful information on COVID-19.

We are in this together – everyone and every part of the Australian healthcare system and community has an essential role to play. It is imperative we work closely together now in a collaborative and organised way to help us get through these challenging times.

Our Responsibility as Medicines Australia and as an industry

As an industry and member of the Australian healthcare community – our critical priorities, at the present time, must be:

  • Focusing our expertise and capabilities in the fight against COVID19 – to uncover the urgently needed measures to protect and treat the community.
  • Ensuring the supply of essential medicines to patients in our community who need them.
  • Working collaboratively with Government and other organisations to actively manage and pre-empt the healthcare delivery needs as they emerge.
  • Recognising and supporting Australia’s healthcare professionals working on the frontline.
  • Working with Healthcare Organisations, Consumer Groups and Patient Advocacy groups to ensure they are kept up to date with relevant information to share with their communities.
  • Our collaboration with research institutions will continue to ensure they have support needed to maintain their important scientific work. This includes maintaining clinical trials, where feasible, to facilitate their completion and assessment.
  • We continue to work with the Therapeutic Goods Administration and Pharmaceutical Benefits Advisory Committee to introduce new medicines and vaccines as they become available.

Medicines supply to the community

In these difficult times we want to reinforce the following

  • Australia has sufficient supplies of medicines and we strongly discourage stockpiling or panic buying of medicines, please only obtain the medicines you immediately need.
  • We have encouraged pharmacists and GPs to help manage our supply of medicines and support the Government’s purchasing limits on selected medicines;
  • We are working in close partnership with Federal (and State) Governments and the local healthcare community to respond to the unprecedented surge in demand.
  • As an industry our companies are working around the clock to monitor and assess our supplies, locally and globally, to ensure they can get to where they are needed.
  • Our manufacturing facilities around the world are open and continue to make millions of doses of medicines and vaccines every day. Strict measures are in place to ensure our teams and facilities are protected and able to maintain production.
  • We want to ensure everyone works together on this – including pharmacists and doctors – so we can ensure our medicines are available to everyone that needs them.

Continuity of Care Collaboration

An open letter to all Australians (amended August 2021)

Medicines Australia is a founding partner of the Continuity of Care Collaboration (CCC). The CCC is a communication collaboration and is made up of over 40 organisations of Peak Bodies, Industry and Healthcare Organisations coming together to stress the importance for people to continue with monitoring their health status and conditions to ensure optimal long term health outcomes are achieved.  The CCC represents the broad healthcare ecosystem and is the first ever such collaboration.

The CCC is advocating for people to continue with their health management during the COVID-19 pandemic and preparing for the future.  The aim is to communicate consistently the importance of people to keep a close watch on their ongoing health care and maintenance, and to not allow the ongoing COVID-19 crisis to prevent this crucial healthcare activity.

The CCC has been awarded the Best Public Health Initiative in the 2020 Prime Awards.

The CCC is advocating for people to continue with their health management during the COVID-19 pandemic.  The aim is to communicate consistently the importance of looking after your health, whether that is managing a chronic health condition, getting preventative screening tests or pathology tests, or seeking immediate treatment and care if you have urgent and/or new symptoms. 

If you would like to know more about the CCC, please click here

A range of social media materials has been developed and is available for adaptation and use. Please click here to view

CCC Webinars

The Future of Healthcare


The CCC has launched the #dontwaitmate campaign to help people, patients and carers in Australia feel safe to continue to go and see their doctor, nurse, pharmacist, allied health professional and dentist, and to also not put of tests such as blood tests, cancer screening or x-rays and scans.

Get involved and help us get the message out there.  Social and comms toolkit is available here in Zip format.  For more information on how you can get involved click here.

Frequently asked questions

Practical tips and information for patients

Here are links to practical and useful information to support patients during these challenging times:

  • Coronavirus (COVID-19) – Official Australian Government information
  • COVID-19 Hotline 1800 020 080.
  • Consumer Health Forum (CHF) – CHF has been extremely busy on two fronts: Providing essential patient information on COVID-19 and advocating for policy change to help support patient and healthcare professionals safety during the COVID-19 pandemic.
  • World Health Organization (WHO) – provides up to date information from an international perspective around COVID-19.
  • List of helpful resources for maintaining your mental health during social isolation.

Regular e-newsletters to HCOs

Here are a list of recent email updates that have been sent out to Health Consumer Organisations by Medicines Australia.

If you want to subscribe to our e-newsletters or find out more information about our work, please email pkeogh@medaus.com.au